A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Conditions
Cancer · Cancer, Lung
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Jacob Thomas, MD)Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Principal Investigator (Carlos R Becerra, MD)UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States
Contact: Principal Investigator (Lee S. Rosen, MD)Sarah Cannon Research Institute (SCRI) at HealthONE, Denver, Colorado, United States
Contact: Principal Investigator (Gerald Falchook, MD, MS)AdventHealth Cancer Institute, Celebration, Florida, United States
Contact: Principal Investigator (Guru P. Sonpavde, MD)Florida Cancer Specialists, Sarasota, Florida, United States
Contact: Principal Investigator (Manish Patel, MD)Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Contact: Principal Investigator (Konstantin Dragnev, MD)Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Anshu Giri, MD)SCRI Oncology Partners, Nashville, Tennessee, United States
Contact: Principal Investigator (Melissa L Johnson, MD)NEXT Dallas, Dallas, Texas, United States
Contact: Study coordinator (Shiraj Sen, MD)NEXT Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Alex Spira, MD)Cross Cancer Institute, Edmonton, Alberta, Canada
Contact: Principal Investigator (Quincy Chu, MD)Juravinski Cancer Centre, Hamilton, Ontario, Canada
Contact: Principal Investigator (Rosalyn Juergens, MD, PhD)Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (Laswson Eng, MD)